May 8, 2008

New Analysis In Boys And Girls Shows The ADHD Patch, DAYTRANA(TM), Offered ADHD Symptom Control For 12 Months (Medical News Today)

window.document.getElementById(’post-41′).parentNode.className += ‘ adhesive_post’;Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRANAâ„¢ (methylphenidate transdermal system) between boys and girls aged 6 to 12 years with Attention Deficit Hyperactivity Disorder (ADHD).

Original post by Epinions Recent Content for Golf

Filed under golf business by

del.icio.us Digg Furl Reddit Ask Google Newsvine Slashdot Spurl Tailrank Technorati Windows Live Yahoo! Help

Permalink • Print • Comment

Trackback uri

http://www.strictlysports.com/golf_product_news/2008/05/08/new-analysis-in-boys-and-girls-shows-the-adhd-patch-daytranatm-offered-adhd-symptom-control-for-12-months-medical-news-today/trackback/

Leave a comment

You must be logged in to post a comment.



Related Posts
  • New Analysis In Boys And Girls Shows The ADHD Patch, DAYTRANA(TM) (methylphenidate Transdermal System), Offered ADHD … (Medical News Today)
  • New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD … (PR Newswire via Yahoo! Finance)
  • New analysis shows DAYTRANA offered ADHD symptom control for 12 months (EurekAlert!)
  • Head coaches salaries by town (Saugus Advertiser)
  • Football Dragons update; fall paperwork, physicals needed; Rush tomorrow (Sonoma Index-Tribune)
    • Make A Difference After 50 | StrictlySports Home | My Wishes My Legacy | Lower Pharmaceutical Drug Prices | Consultative Citizen Participation (Dialogue)
    Made with WordPress and a search engine optimized WordPress theme • Digital Moon skin by Denis de Bernardy